Therefore, this study aims to characterize the efficacy and mechanism of the synthetic derivative of methyl gallate, which is hypothesized to be a potent inhibitor and binds specifically to the active site, in alleviating the disease progression of a chronic inflammatory disease, RA, in terms of LOX, COX-2 and cytokines. This evidence concerns the gene PTGS2 and rheumatoid arthritis.